355819-02-2 Usage
General Description
6-BOC-3-AMINO-5,6,7,8-TETRAHYDRO-[1,6]NAPHTHYRIDINE is a chemical compound with the molecular formula C18H25N3O2. It belongs to the class of tetrahydronaphthyridine compounds and is commonly used in the field of organic chemistry and pharmaceutical research. The BOC in its name stands for tert-butyloxycarbonyl, which is a protecting group for the amino group. 6-BOC-3-AMINO-5,6,7,8-TETRAHYDRO-[1,6]NAPHTHYRIDINE has potential applications in medicinal chemistry, particularly in the development of new drugs and therapeutic agents. It may also have uses in chemical synthesis and as a building block for the creation of more complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 355819-02-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,5,8,1 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 355819-02:
(8*3)+(7*5)+(6*5)+(5*8)+(4*1)+(3*9)+(2*0)+(1*2)=162
162 % 10 = 2
So 355819-02-2 is a valid CAS Registry Number.
355819-02-2Relevant articles and documents
COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
-
Paragraph 00545-00546, (2021/11/26)
Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors described herein.
RESORCINOL DERIVATIVE AS HSP90 INHIBITOR
-
Paragraph 0092, (2017/12/27)
The present invention relates to a compound represented by formula (I) of a resorcinol derivative as an HSP90 inhibitor or pharmaceutically accepted salts thereof. The compound in the present invention has the activity of inhibiting heat shock protein HSP90. Therefore, the compound in the present invention is used to treat proliferative diseases such as cancer and neurodegenerative diseases. The present invention further provides the compounds and preparation methods for pharmaceutical compositions comprising the compounds, a method for treating diseases, and pharmaceutical compositions comprising the compounds.
